Cantor Fitzgerald Upgrades Anteris Technologies Global (NASDAQ:AVR) to Strong-Buy

Anteris Technologies Global (NASDAQ:AVR) was upgraded by equities research analysts at Cantor Fitzgerald to a “strong-buy” rating in a research report issued to clients and investors on Wednesday,Zacks.com reports.

Other analysts have also recently issued reports about the stock. Weiss Ratings reissued a “sell (e+)” rating on shares of Anteris Technologies Global in a report on Monday, December 29th. Lake Street Capital reaffirmed a “buy” rating and set a $15.00 price objective on shares of Anteris Technologies Global in a research report on Friday, January 23rd. One investment analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating and one has issued a Sell rating to the company. According to MarketBeat, Anteris Technologies Global has a consensus rating of “Moderate Buy” and an average target price of $15.00.

Anteris Technologies Global Stock Down 1.4%

Shares of NASDAQ:AVR opened at $6.35 on Wednesday. The company has a current ratio of 0.73, a quick ratio of 0.73 and a debt-to-equity ratio of 0.01. The company has a fifty day simple moving average of $5.62 and a 200 day simple moving average of $4.89. The firm has a market cap of $261.62 million, a PE ratio of -2.48 and a beta of 1.15. Anteris Technologies Global has a 12-month low of $2.34 and a 12-month high of $8.36.

Anteris Technologies Global (NASDAQ:AVR) last released its earnings results on Thursday, February 26th. The company reported ($0.75) EPS for the quarter. The firm had revenue of $0.31 million for the quarter. Anteris Technologies Global had a negative return on equity of 536.04% and a negative net margin of 4,921.27%. On average, equities research analysts anticipate that Anteris Technologies Global will post -2.66 EPS for the current fiscal year.

Insider Activity

In other news, major shareholder L1 Capital Pty Ltd purchased 5,000,000 shares of the stock in a transaction dated Thursday, January 22nd. The stock was acquired at an average price of $5.75 per share, for a total transaction of $28,750,000.00. Following the completion of the transaction, the insider owned 13,219,814 shares of the company’s stock, valued at approximately $76,013,930.50. The trade was a 60.83% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Company insiders own 4.50% of the company’s stock.

Institutional Trading of Anteris Technologies Global

Hedge funds have recently bought and sold shares of the company. ADAR1 Capital Management LLC grew its position in Anteris Technologies Global by 526.9% in the 4th quarter. ADAR1 Capital Management LLC now owns 1,238,777 shares of the company’s stock worth $6,181,000 after purchasing an additional 1,041,162 shares during the last quarter. Millennium Management LLC raised its holdings in shares of Anteris Technologies Global by 21.7% during the fourth quarter. Millennium Management LLC now owns 85,646 shares of the company’s stock valued at $427,000 after buying an additional 15,266 shares during the last quarter. Bridgeway Capital Management LLC acquired a new position in shares of Anteris Technologies Global during the fourth quarter worth approximately $175,000. Price T Rowe Associates Inc. MD grew its holdings in Anteris Technologies Global by 78.7% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 22,875 shares of the company’s stock worth $115,000 after buying an additional 10,073 shares in the last quarter. Finally, Barclays PLC grew its holdings in Anteris Technologies Global by 3.0% in the 4th quarter. Barclays PLC now owns 148,128 shares of the company’s stock worth $739,000 after buying an additional 4,289 shares in the last quarter.

About Anteris Technologies Global

Anteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.